Chandra Bhagat Pharma Ltd Share Price

69.39
(1.82%)
Jul 23, 2024|03:40:00 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open67.25
  • Day's High69.39
  • 52 Wk High160
  • Prev. Close68.15
  • Day's Low66.6
  • 52 Wk Low63
  • Turnover (lac)2.77
  • P/E33.57
  • Face Value10
  • Book Value38.44
  • EPS2.03
  • Mkt. Cap (Cr.)52.36
  • Div. Yield0
No Records Found

Chandra Bhagat Pharma Ltd KEY RATIOS

Sector

Trading

Open

67.25

Prev. Close

68.15

Turnover(Lac.)

2.77

Day's High

69.39

Day's Low

66.6

52 Week's High

160

52 Week's Low

63

Book Value

38.44

Face Value

10

Mkt Cap (₹ Cr.)

52.36

P/E

33.57

EPS

2.03

Divi. Yield

0

Chandra Bhagat Pharma Ltd Corporate Action

6 Sep 2023

12:00 AM

BookCloser

arrow

5 Sep 2023

12:00 AM

AGM

Announcement Date: 05 Sep, 2023

arrow

23 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Chandra Bhagat Pharma Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Chandra Bhagat Pharma Ltd SHAREHOLDING SNAPSHOT

23 Jul, 2024|04:24 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 68.77%

Foreign: 0.00%

Indian: 68.77%

Non-Promoter- 2.21%

Institutions: 2.21%

Non-Institutions: 29.01%

Custodian: 0.00%

Share Price

Chandra Bhagat Pharma Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

7.55

7.55

7.55

7.55

Preference Capital

0

0

0

0

Reserves

19.93

19.13

18.33

18.14

Net Worth

27.48

26.68

25.88

25.69

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2020Mar-2019

Revenue

93.98

106.27

yoy growth (%)

-11.57

Raw materials

-85.79

-92.36

As % of sales

91.29

86.91

Employee costs

-2.44

-4.71

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2020Mar-2019

Profit before tax

0.42

0.88

Depreciation

-0.03

-0.05

Tax paid

-0.1

-0.19

Working capital

12.58

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2020Mar-2019

Growth matrix (%)

Revenue growth

-11.57

Op profit growth

-27.47

EBIT growth

-24.64

Net profit growth

-54.28

View Ratios

No Record found

Chandra Bhagat Pharma Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Adani Enterprises Ltd

ADANIENT

3,000.15

122.463,42,017.44776.710.049,210.18145.96

Aegis Logistics Ltd

AEGISLOG

844.95

73.0929,657.75125.880.38721.5167.87

Cello World Ltd

CELLO

948.55

339.9820,952.0518.620.15260.7765.65

Redington Ltd

REDINGTON

202.4

15.2115,823.11160.573.0610,490.2446.35

Honasa Consumer Ltd

HONASA

463.4

124.2415,025.4726.710427.1734.67

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Chandra Bhagat Pharma Ltd

Management

Register Office

Registrar Office

Chairman & Managing Director

Hemant C Bhagat

Whole-time Director

Pranav H Bhagat

Director & CFO

Prachi Pranav Bhagat

Independent Director

Ravindra Gajanan Awati

Independent Director

Abha Praveen Doshi

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Chandra Bhagat Pharma Limited was incorporated as a private limited company with the name Chandra Bhagat Pharma Private Limited at Mumbai on March 10, 2003. Consequent upon the conversion of the Company from Private Limited Company to Public Limited Company, the name of the Company was changed to Chandra Bhagat Pharma Limited on March 20, 2019.Inspirited by its founder Late Shree Chandravadan Bhagats sense of personal mission, the company is driven to fill the gap in pharma sector especially in critical lifesaving medicines in India. The Company was incorporated on March 10, 2003 by Mr. Hemant Bhagat and Late. Shree Chandravadan Bhagat. On April 1, 2003, the company acquired the going concern business of M/s. Chandra Bhagat Corporation (partnership firm) along with all its assets and liabilities. Consequently, the company issued equity shares to respective partners of M/s. Chandra Bhagat Corporation against the acquisition of going concern business along with all its assets and liabilities. The promoter Mr. Hemant Bhagat decided to continue on the footsteps of his father Late Shree Chandravadan Bhagat by focusing on marketing of life saving medicines like Antibiotics, Antineoplastic, Cardiovascular, Hormones etc. and set up the companys marketing force in order to wider the product portfolio. Subsequently in the year 2004, the promoter Mr. Pranav Bhagat son of Mr. Hemant Bhagat, being third generation also joined the business and decided to market the pharmaceuticals and spec
Read More

Company FAQs

What is the Chandra Bhagat Pharma Ltd share price today?

Down Arrow

The Chandra Bhagat Pharma Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹69.39 today.

What is the Market Cap of Chandra Bhagat Pharma Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Chandra Bhagat Pharma Ltd is ₹52.36 Cr. as of 23 Jul ‘24

What is the PE and PB ratio of Chandra Bhagat Pharma Ltd?

Down Arrow

The PE and PB ratios of Chandra Bhagat Pharma Ltd is 33.57 and 1.77 as of 23 Jul ‘24

What is the 52 Week High and Low of Chandra Bhagat Pharma Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Chandra Bhagat Pharma Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Chandra Bhagat Pharma Ltd is ₹63 and ₹160 as of 23 Jul ‘24

What is the CAGR of Chandra Bhagat Pharma Ltd?

Down Arrow

Chandra Bhagat Pharma Ltd's CAGR for 5 Years at 5.66%, 3 Years at -7.82%, 1 Year at -39.29%, 6 Month at -43.40%, 3 Month at -39.02% and 1 Month at -20.76%.

What is the shareholding pattern of Chandra Bhagat Pharma Ltd?

Down Arrow

The shareholding pattern of Chandra Bhagat Pharma Ltd is as follows:
Promoters - 68.77 %
Institutions - 2.21 %
Public - 29.01 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.